Top

CardioVascular and Interventional Radiology

Published in:

01-04-2017 | Laboratory Investigation

Chitosan–Sodium Tetradecyl Sulfate Hydrogel: Characterization and Preclinical Evaluation of a Novel Sclerosing Embolizing Agent for the Treatment of Endoleaks

Authors: Fatemeh Zehtabi, Vincent Dumont-Mackay, Ahmed Fatimi, Antony Bertrand-Grenier, Hélène Héon, Gilles Soulez, Sophie Lerouge

Published in: CardioVascular and Interventional Radiology | Issue 4/2017

Abstract

Purpose

To compare the efficacy of an embolization agent with sclerosing properties (made of chitosan and sodium tetradecyl sulfate, CH–STS) with a similar embolization agent but without sclerosing properties (made of chitosan, CH) in treating endoleaks in a canine endovascular aneurysm repair model.

Methods

Two chitosan-based radiopaque hydrogels were prepared, one with STS and one without STS. Their rheological, injectability, and embolizing properties were assessed in vitro; afterwards, their efficacy in occluding endoleaks was compared in a canine bilateral aneurysm model reproducing type I endoleaks (n = 9 each). The primary endpoint was endoleak persistence at 3 or 6 months, assessed on a CT scan and macroscopic examination. Secondary endpoints were the occurrence of stent-graft (SG) thrombosis, the evolution of the aneurysm mean diameter, as well as aneurysm healing and inflammation scores in pathology examinations.

Results

In vitro experiments showed that both products gelled rapidly and presented initial storage moduli greater than 800 Pa, which increased with time. Both gels were compatible with microcatheter injection and occlude flow up to physiological pressure in vitro. In a type I endoleak model, the injection of CH–STS sclerosing gel tended to reduce the risk of occurrence of endoleaks, compared to CH non-sclerosing agent (2/9 vs. 6/9, p = 0.069). No case of SG thrombosis was observed. Moderate inflammation was found around both gels, with a comparable intensity score in both CH and CH–STS groups (2.6 ± 0.9 and 2.7 ± 0.9, respectively; p = 0.789).

Conclusions

Flow occlusion combined with chemical endothelial denudation appears promising for the treatment of endoleaks.

Level of Evidence

N/A.

Available only for authorised users

Nevala T, Biancari F, Manninen H, Aho P-S, Matsi P, Mäkinen K, et al. Type II endoleak after endovascular repair of abdominal aortic aneurysm: effectiveness of embolization. Cardiovasc Interv Radiol. 2010;33(2):278–84. doi:10.1007/s00270-009-9685-5.CrossRef

Hiramoto JS, Reilly LM, Schneider DB, Sivamurthy N, Rapp JH, Chuter TAM. Long-term outcome and reintervention after endovascular abdominal aortic aneurysm repair using the Zenith stent graft. J Vasc Surg. 2007;45(3):461–6. doi:10.1016/j.jvs.2006.11.034.CrossRefPubMed

Seriki DM, Ashleigh RJ, Butterfield JS, England A, McCollum CN, Akhtar N, et al. Midterm follow-up of a single-center experience of endovascular repair of abdominal aortic aneurysms with use of the Talent stent-graft. J Vasc Interv Radiol. 2006;17(6):973–7. doi:10.1097/01.RVI.0000222661.64390.3e.CrossRefPubMed

Chung R, Morgan RA. Type 2 endoleaks post-EVAR: current evidence for rupture risk, intervention and outcomes of treatment. Cardiovasc Interv Radiol. 2015;38(3):507–22. doi:10.1007/s00270-014-0987-x.CrossRef

Brewster DC, Jones JE, Chung TK, Lamuraglia GM, Kwolek CJ, Watkins MT, et al. Long-term outcomes after endovascular abdominal aortic aneurysm repair: the first decade. Ann Surg. 2006;244(3):426–38. doi:10.1097/01.sla.0000234893.88045.dc.PubMedPubMedCentral

Khaja MS, Park AW, Swee W, Evans AJ, Fritz Angle J, Turba UC, et al. Treatment of type II endoleak using Onyx with long-term imaging follow-up. Cardiovasc Interv Radiol. 2014;37(3):613–22. doi:10.1007/s00270-013-0706-z.CrossRef

Muller-Wille R, Wohlgemuth WA, Heiss P, Wiggermann P, Guntner O, Schreyer AG, et al. Transarterial embolization of type II endoleaks after EVAR: the role of ethylene vinyl alcohol copolymer (Onyx). Cardiovasc Interv Radiol. 2013;36(5):1288–95. doi:10.1007/s00270-013-0567-5.CrossRef

Sarac TP, Gibbons C, Vargas L, Liu J, Srivastava S, Bena J, et al. Long-term follow-up of type II endoleak embolization reveals the need for close surveillance. J Vasc Surg. 2012;55(1):33–40. doi:10.1016/j.jvs.2011.07.092.CrossRefPubMed

Stavropoulos SW, Kim H, Clark TW, Fairman RM, Velazquez O, Carpenter JP. Embolization of type 2 endoleaks after endovascular repair of abdominal aortic aneurysms with use of cyanoacrylate with or without coils. J Vasc Interv Radiol. 2005;16(6):857–61. doi:10.1097/01.rvi.0000156495.66062.62.CrossRefPubMed

10.

Martin ML, Dolmatch BL, Fry PD, Machan LS. Treatment of type II endoleaks with Onyx. J Vasc Interv Radiol. 2001;12(5):629–32. doi:10.1016/S1051-0443(07)61489-4.CrossRefPubMed

11.

Cao P, De Rango P, Verzini F, Parlani G. Endoleak after endovascular aortic repair: classification, diagnosis and management following endovascular thoracic and abdominal aortic repair. J Cardiovasc Surg. 2010;51(1):53.

12.

Ghouri M, Krajcer Z. Endoluminal abdominal aortic aneurysm repair: the latest advances in prevention of distal endograft migration and type 1 endoleak. Tex Heart Inst J. 2010;37(1):19.PubMedPubMedCentral

13.

Chun JY, Morgan R. Transcatheter embolisation of type 1 endoleaks after endovascular aortic aneurysm repair with Onyx: when no other treatment option is feasible. Eur J Vasc Endovasc Surg. 2013;45(2):141–4. doi:10.1016/j.ejvs.2012.11.010.CrossRefPubMed

14.

Eberhardt KM, Sadeghi-Azandaryani M, Worlicek S, Koeppel T, Reiser MF, Treitl M. Treatment of type I endoleaks using transcatheter embolization with Onyx. J Endovasc Ther. 2014;21(1):162–71. doi:10.1583/13-4349mr2.1.CrossRefPubMed

15.

Henrikson O, Roos H, Falkenberg M. Ethylene vinyl alcohol copolymer (Onyx) to seal type 1 endoleak. A new technique. Vascular. 2011;19(2):77–81. doi:10.1258/vasc.2010.oa0257.CrossRefPubMed

16.

Soulez G, Lerouge S, Darsaut T, Salazkin I, Oliva VL, Raymond J. Role of the endothelial lining in endoleak formation and persistence after endovascular repair of aneurysm. J Vasc Interv Radiol. 2008;19(7):1070–8. doi:10.1016/j.jvir.2008.04.008.CrossRefPubMed

17.

Fatimi A, Chabrot P, Berrahmoune S, Coutu JM, Soulez G, Lerouge S. A new injectable radiopaque chitosan-based sclerosing embolizing hydrogel for endovascular therapies. Acta Biomater. 2012;8(7):2712–21. doi:10.1016/j.actbio.2012.04.006.CrossRefPubMed

18.

Cabrera J, Cabrera J Jr, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol. 2003;139(11):1409–16. doi:10.1001/archderm.139.11.1409.CrossRefPubMed

19.

Dubois J, Soulez G, Oliva VL, Berthiaume MJ, Lapierre C, Therasse E. Soft-tissue venous malformations in adult patients: imaging and therapeutic issues. Radiographics. 2001;21(6):1519–31. doi:10.1148/radiographics.21.6.g01nv031519.CrossRefPubMed

20.

Ahmadi F, Oveisi Z, Samani SM, Amoozgar Z. Chitosan based hydrogels: characteristics and pharmaceutical applications. Res Pharm Sci. 2015;10(1):1–16.PubMedPubMedCentral

21.

Fatimi A, Zehtabi F, Lerouge S. Optimization and characterization of injectable chitosan-iodixanol-based hydrogels for the embolization of blood vessels. J Biomed Mater Res B Appl Biomater. 2016;104B(8):1551–1562. doi:10.1002/jbm.b.33500.CrossRef

22.

Soulez G, Lerouge S, Salazkin I, Darsaut T, Oliva VL, Raymond J. Type I and collateral flow in experimental aneurysm models treated with stent-grafts. J Vasc Interv Radiol. 2007;18(2):265–72. doi:10.1016/j.jvir.2006.12.728.CrossRefPubMed

23.

Lerouge S, Raymond J, Salazkin I, Qin Z, Gaboury L, Cloutier G, et al. Endovascular aortic aneurysm repair with stent-grafts: experimental models can reproduce endoleaks. J Vasc Interv Radiol. 2004;15(9):971–9. doi:10.1097/01.rvi.0000130816.33038.ed.CrossRefPubMed

24.

Stavropoulos SW, Clark TWI, Carpenter JP, Fairman RM, Litt H, Velazquez OC, et al. Use of CT angiography to classify endoleaks after endovascular repair of abdominal aortic aneurysms. J Vasc Interv Radiol. 2005;16(5):663–7. doi:10.1097/01.RVI.0000152386.97448.F1.CrossRefPubMed

25.

Carter AJ, Aggarwal M, Kopia GA, Tio F, Tsao PS, Kolata R, et al. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res. 2004;63(4):617–24. doi:10.1016/j.cardiores.2004.04.029.CrossRefPubMed

26.

Lerouge S, Bonneviot MC, Salazkin I, Raymond J, Soulez G. Endothelial denudation combined with embolization in the prevention of endoleaks after endovascular aneurysm repair: an animal study. J Endovasc Ther. 2011;18(5):686–96. doi:10.1583/11-3541.1.CrossRefPubMed

27.

Hamada J, Kai Y, Morioka M, Kazekawa K, Ishimaru Y, Iwata H, et al. A mixture of ethylene vinyl alcohol copolymer and ethanol yielding a nonadhesive liquid embolic agent to treat cerebral arteriovenous malformations: initial clinical experience. J Neurosurg. 2002;97(4):881–8. doi:10.3171/jns.2002.97.4.0881.CrossRefPubMed

28.

Dompmartin A, Blaizot X, Theron J, Hammer F, Chene Y, Labbe D, et al. Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations. Eur Radiol. 2011;21(12):2647–56. doi:10.1007/s00330-011-2213-4.CrossRefPubMed

29.

Nakai M, Ikoma A, Sato M, Sato H, Nishimura Y, Okamura Y. Prophylactic intraoperative embolization of abdominal aortic aneurysm sacs using N-butyl cyanoacrylate/lipiodol/ethanol mixture with proximal neck aortic balloon occlusion during endovascular abdominal aortic repair. J Vasc Interv Radiol. 2016;27(7):954–60. doi:10.1016/j.jvir.2016.03.037.CrossRefPubMed

30.

Chenite A, Buschmann M, Wang D, Chaput C, Kandani N. Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutions. Carbohydr Polym. 2001;46(1):39–47. doi:10.1016/S0144-8617(00)00281-2.CrossRef

31.

Coutu JM, Fatimi A, Berrahmoune S, Soulez G, Lerouge S. A new radiopaque embolizing agent for the treatment of endoleaks after endovascular repair: influence of contrast agent on chitosan thermogel properties. J Biomed Mater Res B Appl Biomater. 2013;101(1):153–61. doi:10.1002/jbm.b.32828.CrossRefPubMed

32.

Saeed Kilani M, Izaaryene J, Cohen F, Varoquaux A, Gaubert JY, Louis G, et al. Ethylene vinyl alcohol copolymer (Onyx(R)) in peripheral interventional radiology: indications, advantages and limitations. Diagn Interv Imaging. 2015;96(4):319–26. doi:10.1016/j.diii.2014.11.030.CrossRefPubMed

33.

Ganji F, Abdekhodaie MJ, Ramazani SAA. Gelation time and degradation rate of chitosan-based injectable hydrogel. J Sol Gel Sci Technol. 2007;42(1):47–53. doi:10.1007/s10971-006-9007-1.CrossRef

34.

Adolph R, Vorp DA, Steed DL, Webster MW, Kameneva MV, Watkins SC. Cellular content and permeability of intraluminal thrombus in abdominal aortic aneurysm. J Vasc Surg. 1997;25(5):916–26. doi:10.1016/S0741-5214(97)70223-4.CrossRefPubMed

Title: Chitosan–Sodium Tetradecyl Sulfate Hydrogel: Characterization and Preclinical Evaluation of a Novel Sclerosing Embolizing Agent for the Treatment of Endoleaks
Authors: Fatemeh Zehtabi
Vincent Dumont-Mackay
Ahmed Fatimi
Antony Bertrand-Grenier
Hélène Héon
Gilles Soulez
Sophie Lerouge
Publication date: 01-04-2017
Publisher: Springer US
Published in: CardioVascular and Interventional Radiology / Issue 4/2017
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-016-1557-1

At a glance: The STEP trials

Springer Medicine

Chitosan–Sodium Tetradecyl Sulfate Hydrogel: Characterization and Preclinical Evaluation of a Novel Sclerosing Embolizing Agent for the Treatment of Endoleaks

Abstract

Purpose

Methods

Results

Conclusions

Level of Evidence

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Level of Evidence

Please log in to get access to this content

Other articles of this Issue 4/2017

Comparison of Inversion (“flipping”) Rates Among Different Port Designs: A Single-Center Experience

The Results of Ultrasonography-Guided Percutaneous Radiofrequency Ablation in Hyperparathyroid Patients in Whom Surgery Is Not Feasible

Trerotola Device Fragmentation

The IR Point of View: Action Cameras for IR Action

Post-procedural Care in Interventional Radiology: What Every Interventional Radiologist Should Know—Part I: Standard Post-procedural Instructions and Follow-Up Care

Percutaneous Biopsy of Retrobulbar Masses: Anatomical Considerations and MRI Guidance